Hyperfine, Inc. Class A Common Stock earnings per share and revenue
On Nov 13, 2025, HYPR reported earnings of -0.11 USD per share (EPS) for Q3 25, missing the estimate of -0.10 USD, resulting in a -2.71% surprise. Revenue reached 3.44 million, compared to an expected 3.53 million, with a -2.61% difference. The market reacted with a +9.52% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.08 USD, with revenue projected to reach 5.26 million USD, implying an decrease of -27.27% EPS, and increase of 52.99% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.63%
FAQ
What were Hyperfine, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Hyperfine, Inc. Class A Common Stock reported EPS of -$0.11, missing estimates by -2.71%, and revenue of $3.44M, -2.61% below expectations.
How did the market react to Hyperfine, Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved up 9.52%, changed from $1.05 before the earnings release to $1.15 the day after.
When is Hyperfine, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Mar 16, 2026.
What are the forecasts for Hyperfine, Inc. Class A Common Stock's next earnings report?
Based on 4
analysts, Hyperfine, Inc. Class A Common Stock is expected to report EPS of -$0.08 and revenue of $5.26M for Q4 2025.